EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Postoperative prophylactic and delayed oral antibiotics after total shoulder arthroplasty: a multi-institutional database analysis

Tarek Haj Shehadeh, Anjan Singh, Jawaad Chaudhry, Nathan Lanham

Clinics in Shoulder and Elbow · 2026-11-09

DOI: 10.5397/cise.2026.00374 ↗
AbstractBibliografische Angaben

Abstract

Background: To evaluate the effectiveness and safety of prophylactic and delayed postoperative oral antibiotics following total shoulder arthroplasty (TSA). Methods: The TriNetX database was queried for primary TSA patients. Those with prior pathologic fracture, upper extremity malignancy, infection, prosthetic joint infection (PJI), or revision surgery within 6 months were excluded. After 1:1 propensity score matching, two comparisons were performed: (1) prophylactic oral antibiotics within 1 postoperative day versus controls (n=5,891 per cohort) and (2) delayed oral antibiotics on postoperative days 7–30 versus controls (n=3,087 per cohort). Outcomes at 30 and 90 days included acute kidney injury (AKI), emergency department (ED) visits, readmission, PJI, and revision surgery. Results: At 30 days, prophylactic antibiotics were associated with fewer readmissions (2.78% vs. 3.73%; P=0.004), with no differences in AKI, ED visits, PJI, or revision surgery. At 90 days, they were associated with higher PJI (0.92% vs. 0.48%; P=0.004) and a trend toward lower ED visits (5.25% vs. 6.16%; P=0.032) and readmissions (3.70% vs. 4.67%; P=0.009), but higher revision surgery (1.17% vs. 0.73%; P=0.014). Delayed antibiotics were associated with higher rates of AKI, ED visits, readmissions, and revision surgery at both 30 and 90 days (all P

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →